-
Mashup Score: 0Durvalumab Added to Standard of Care Improves Survival Outcomes for Patients With Muscle-Invasive Urothelial Carcinoma - 7 month(s) ago
According to a phase 2 trial, the additional of durvalumab to neoadjuvant chemotherapy and as an adjuvant treatment following surgery improved event-free survival and overall survival for patients with resectable, muscle-invasive urothelial carcinoma.
Source: www.hmpgloballearningnetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
Original Article from The New England Journal of Medicine — Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
Source: www.nejm.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Please wait whilst we redirect you - 10 month(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Second-line Axi-Cel Improves Overall Survival in Patients With Relapsed/Refractory LBCL - 1 year(s) ago
The primary overall survival analysis of the phase 3 ZUMA-7 trial favors axicabtagene ciloleucel over standard of care therapy.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Second-line Axi-Cel Improves Overall Survival in Patients With Relapsed/Refractory LBCL - 1 year(s) ago
The primary overall survival analysis of the phase 3 ZUMA-7 trial favors axicabtagene ciloleucel over standard of care therapy.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3DNS Manager 5.5.0 - DNS Manager Documentation - 4PSA Wiki - 2 year(s) ago
This document contains all the changes performed in DNS Manager 5.5.0.Important NotesBefore UpgradeUpgrade requires first the upgrade of the operating system to one of the supported versions:Red Hat Enterprise Linux 8AlmaLinux 8Rocky Linux 8The upgrade from CentOS 7 to AlmaLinux 8.6 is possible directly using the toolset released by AlmaLinux.InstallationIn order to install or upgrade to DNS…
Source: wiki.4psa.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 4Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7Please wait whilst we redirect you - 2 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2022 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0
The number of randomized trials of agents targeting oncogene-addicted tumors has surged in the past 10 years. Using a meta-analysis, we explored wheth…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists2Tweet
According to study investigators, “The addition of perioperative #durvalumab to the standard of care for patients with resectable [muscle-invasive urothelial carcinoma] results in high #EFS and #OS at 2 years.” Learn more: https://t.co/eLQP8Z4ozE #onctwitter #medtwitter https://t.co/0N1Ca2aChs